Table 1.
Ref. | Type of diabetes | No. of studies included | Remission percentage (95%CI) |
Chang et al[11], 2014 | Not specified | 164 (37 randomized clinical trials and 127 observational studies) | Randomized clinical trials: 92% (85%-97%) Observational studies: 86% (79%-92%) |
Buchwald et al[12], 2004 | Not specified | 136 | 76.8% (70.7%-82.9%) |
Gloy et al[13], 2013 | Not specified | 11 | 59.90% |
Ashrafian et al[14], 2015 | Type 1 diabetes mellitus | 27 | Weighted mean decrease in insulin requirement: 44.5 units 78.1% (73.8%-82.3%) |
Chow et al[15], 2016 | Type 1 diabetes mellitus | 13 | Weighted mean total daily insulin requirement decreased from 98 +/- 26 IU/d to 42 +/- 11 IU/d |
Mahawar et al[16], 2016 | Type 1 diabetes mellitus | 15 | Not reported |
Buchwald et al[17], 2009 | Type 2 diabetes mellitus | 621 | 76.2% insulin free |
Baskota et al[18], 2015 | Type 2 diabetes mellitus | 10 | 61.8% medication free |
Goh et al[19], 2017 | Type 2 diabetes mellitus | 24 | Remission rate Duodenal-jejunal bypass: 20%-40% Duodenal-jejunal bypass with sleeve gastrectomy: 79%-93% Duodenal-jejunal bypass sleeve: 62.5%-100% Ileal interposition with sleeve gastrectomy: 47%-95.7% |
Yan et al[20] | Type 2 diabetes mellitus | 6 | Type 2 diabetes mellitus remission rate for roux-en-y gastric bypass vs medical treatment: OR: 76.4 (95%CI: 20.7-281.7) |